A case of indolent systemic mastocytosis responding to treatment with Avapritinib

Terrence Sun; Marin Xavier

doi:10.1002/ccr3.8500

A case of indolent systemic mastocytosis responding to treatment with Avapritinib

Clin Case Rep. 2024 Feb 23;12(2):e8500. doi: 10.1002/ccr3.8500. eCollection 2024 Feb.

Authors

Terrence Sun¹, Marin Xavier²

Affiliations

¹ Department of Medicine Internal Medicine Resident, Scripps Mercy Hospital San Diego California USA.
² Division of Hematology/Oncology Scripps Clinic Medical Group, Prebys Cancer Center San Diego California USA.

Abstract

Low dose Avapritinib is a new medication that is a potential treatment option not just for advanced systemic mastocytosis, but also for the indolent form.

Keywords: Avapritinib; hematology; immunology; oncology; systemic mastocytosis.

Publication types

Case Reports